Cardiology

Back to articles

Dual antiplatelet therapy: Three months may be enough with newer stents

KEY POINT

In patients with stable coronary artery disease or low-risk acute coronary syndrome (ACS) who underwent percutaneous coronary intervention (PCI) with a drug-eluting stent, 3 months of dual antiplatelet therapy (DAPT) was noninferior to 12 months in preventing death, myocardial infarction (MI), stroke, or major bleeding.